Literature DB >> 2502517

Induction of uterine hemangioendothelioma and lymphoma in (C57BL/6N x C3H/2N)F1 mice by oral administration of azathioprine.

A Ito1, M Mori, M Naito.   

Abstract

The tumorigenicity of 6-(1-methyl-4-nitro-5-imidazolyl)mercaptopurine (azathioprine), an immunosuppressant, was examined in (C57BL/6N X C3H/2N)F1 mice. Animals were divided into 6 groups with 50 mice in each group, and they were given powdered diet mixed with 0, 5 or 20 ppm azathioprine starting at 6 weeks and ending at 100 weeks of age. Female mice, given 20 ppm azathioprine, developed lymphomas and uterine hemangioendotheliomas at incidences of 12.5 and 14.6%, respectively, which were significantly higher than the incidences in control mice (P less than 0.05). Lymphoma and uterine hemangioendothelioma developed independently in different mice. On the other hand, the male mice given 20 ppm azathioprine had a significantly (P less than 0.05) lower incidence of hepatic tumor (0.5%) compared to the control mice (16%).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502517      PMCID: PMC5917757          DOI: 10.1111/j.1349-7006.1989.tb02330.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  Accelerated development of spontaneous thymic lymphomas in male AKR mice receiving cyclosporine.

Authors:  A Hattori; M I Perera; L A Witkowski; H W Kunz; T J Gill; H Shinozuka
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

Review 2.  Malignancies associated with immunosuppressive or cytotoxic therapy.

Authors:  I Penn
Journal:  Surgery       Date:  1978-05       Impact factor: 3.982

3.  Synergistic action of N-nitrosobutylurea and azathioprine in induction of leukemia in C57BL mice.

Authors:  N Imamura; M Nakano; A Kawase; Y Kawamura; K Yokoro
Journal:  Gan       Date:  1973-10

Review 4.  Immunobiology of cyclosporin A--a review.

Authors:  A W Thomson
Journal:  Aust J Exp Biol Med Sci       Date:  1983-04

5.  Tumorigenicity test of N-(5-Nitro-2-furfurylidene)-1-aminohydantoin by dietary administration in BDF1 mice.

Authors:  A Ito; M Naito; Y Naito; H Watanabe
Journal:  Hiroshima J Med Sci       Date:  1983-03

6.  Azathioprine.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum       Date:  1981-05

7.  Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice.

Authors:  J M Ward; D G Goodman; R A Squire; K C Chu; M S Linhart
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506

8.  The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide.

Authors:  P S Mitrou; M Fischer; G Mitrou; P Röttger; G Holtz
Journal:  Arzneimittelforschung       Date:  1979

9.  Azathioprine induction of lymphomas and squamous cell carcinomas in rats.

Authors:  S M Cohen; E Erturk; J L Skibba; G T Bryan
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

10.  Sequential analyses of the development of lymphoproliferative disorders in rats receiving cyclosporine.

Authors:  A J Demetris; M A Nalesnik; H W Kunz; T J Gill; H Shinozuka
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

View more
  4 in total

1.  Left main coronary stenosis by a mediastinal lymphoma.

Authors:  U Zeymer; W D Hirschmann; K L Neuhaus
Journal:  Clin Investig       Date:  1992-11

Review 2.  Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993.

Authors:  L S Gold; N B Manley; T H Slone; G B Garfinkel; B N Ames; L Rohrbach; B R Stern; K Chow
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

3.  Significance of strain and sex differences in the development of 252Cf neutron-induced liver tumors in mice.

Authors:  A Ito; T Takahashi; H Watanabe; P O Ogundigie; T Okamoto
Journal:  Jpn J Cancer Res       Date:  1992-10

Review 4.  Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans.

Authors:  Daniel Krewski; Jerry M Rice; Michael Bird; Brittany Milton; Brian Collins; Pascale Lajoie; Mélissa Billard; Yann Grosse; Vincent J Cogliano; Jane C Caldwell; Ivan I Rusyn; Christopher J Portier; Ronald L Melnick; Robert A Baan; Julian Little; Jan M Zielinski
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2019       Impact factor: 6.393

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.